Abstract:Genetic analysis of variation demands large numbers of individuals and even larger numbers of genotypes. The identification of alleles associated with Mendelian disorders has involved sample sizes of a thousand or more. Pervasive and common diseases that afflict human populations--cancer, heart disease, diabetes, neurodegeneration, addiction--are all polygenic and are even more demanding of large numbers. DeCode Genetics (http://www.decode.com) has harnessed the human resources of Iceland to unravel genetic and molecular causes of complex disease. The UK BioBank project (http://www.ukbiobank.ac.uk/) will incorporate 500,000 adult volunteers. The murine Collaborative Cross is the experimental equivalent of these human populations and will consist of a panel of approximately 1000 recombinant strains, expandable by intercrossing to much larger numbers of isogenic but heterozygous F(1)s. Massive projects of these types require efficient technologies. We have made enormous progress on the genotyping front, and it is now important to focus energy on devising ultrahigh-throughput methods to phenotype. Molecular phenotyping of the transcriptome has matured, and it is now possible to acquire hundreds of thousands of mRNA phenotypes at a cost matching those of SNPs. Proteomic and cell-based assays are also maturing rapidly. The acquisition of a personal genome along with a personal molecular phenome will provide an effective foundation for personalized medicine. Rodent models will be essential to test our ability to predict susceptibility and disease outcome using SNP data, molecular phenomes, and environmental exposures. These models will also be essential to test new treatments in a robust systems context that accounts for genetic variation.

The genomic case against genetic determinism

Philosophical Thinking of Schizophrenia Genetic Study

Molecular genetics in psychology and personality neuroscience: On candidate genes, genome wide scans, and new research strategies

Bioinformatics in Psychiatric Genetics

How Genetic-Conflict Theory Can Inform Studies of Human Nature

The Future of Genetic Studies of Complex Human Diseases

Layers of epistasis: genome‐wide regulatory networks and network approaches to genome‐wide association studies

The genetics revolution. Ethical, legal, and insurance concerns

Environment and genes. Determinants of behavior.

The myth of genetic enhancement

The Genome-Wide Study of Human Social Behavior and Its Application in Sociology

Genomic Essentialism: Its Provenance and Trajectory as an Anticipatory Ethical Concern

Genes in context: path to more precise risk prediction in psychiatry?

Expression genetics and the phenotype revolution

Advancing Mental Health Research Through Strategic Integration of Transdiagnostic Dimensions and Genomics

Genomic Architecture of Human Neuroanatomical Diversity

Unravelling the genetic basis of Schizophrenia

Using a comprehensive atlas and predictive models to reveal the complexity and evolution of brain-active regulatory elements

Incorporation of Biological Knowledge Into the Study of Gene-Environment Interactions

Genomic and epigenomic insights into nutrition and brain disorders

Perspective on recent developments and challenges in regulatory and systems genomics